Efficacy of Immune Checkpoint Inhibitors in Metastatic Melanoma (MM) Patients with Concurrent Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Guerra, Veronica [1 ]
Ologun, Gabriel [2 ]
Haydu, Lauren [2 ]
Keung, Emily [2 ]
Burton, Elizabeth [2 ]
Tawbi, Hussein [3 ]
Davis, Michael [3 ]
Wargo, Jennifer [2 ]
Ferrajoli, Alessandra [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
chronic lymphocytic leukemia; CLL; melanoma; immune checkpoint inhibitors; nivolumab; ipilimumab; pembrolizumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-229
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [21] Posterior cord syndrome associated with immune checkpoint inhibitors for metastatic melanoma
    Secco, L. -p.
    Lesage, C.
    Lippi, A.
    Maria, A.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2021, 148 (03): : 193 - 194
  • [22] Immune Checkpoint Inhibitors for Treatment of Metastatic Melanoma of the Orbit and Ocular Adnexa
    Ford, Joshua
    Thuro, Bradley A.
    Thakar, Sudip
    Hwu, Wen-Jen
    Richani, Karina
    Esmaeli, Bita
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 33 (04) : E82 - E85
  • [23] Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases
    Di Nunno, Vincenzo
    Nuvola, Giacomo
    Mosca, Mirta
    Maggio, Ilaria
    Gatto, Lidia
    Tosoni, Alicia
    Lodi, Raffaele
    Franceschi, Enrico
    Brandes, Alba Ariela
    IMMUNOTHERAPY, 2021, 13 (05) : 419 - 432
  • [24] Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy
    Mohamad, Osama
    de Leon, Alberto Diaz
    Schroeder, Samuel
    Leiker, Andrew
    Christie, Alana
    Zhang-Velten, Elizabeth
    Trivedi, Lakshya
    Khan, Saad
    Desai, Neil B.
    Laine, Aaron
    Albuquerque, Kevin
    Iyengar, Puneeth
    Arriaga, Yull
    Courtney, Kevin
    Gerber, David E.
    Hammers, Hans
    Choy, Hak
    Timmerman, Robert
    Brugarolas, James
    Hannan, Raquibul
    ONCOIMMUNOLOGY, 2018, 7 (07):
  • [25] PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
    Gabrys, H. S.
    Basler, L.
    Burgermeister, S.
    Hogan, S.
    Ahmadsei, M.
    Pavic, M.
    Bogowicz, M.
    Vuong, D.
    Tanadini-Lang, S.
    Foerster, R.
    Kudura, K.
    Huellner, M.
    Dummer, R.
    Levesque, M. P.
    Guckenberger, M.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] B Cell Subsets and Immune Checkpoint Expression in Patients with Chronic Lymphocytic Leukemia
    Ntsethe, Aviwe
    Mkhwanazi, Zekhethelo Alondwe
    Dludla, Phiwayinkosi Vusi
    Nkambule, Bongani Brian
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (03) : 1731 - 1740
  • [27] Impact of prior treatment with immune checkpoint inhibitors on dacarbazine efficacy in metastatic melanoma
    Bouchereau, Sarah
    Chaplain, Louise
    Fort, Magali
    Beauchet, Alain
    Sidibe, Thomas
    Chapalain, Marie
    Gonzalez-Lara, Leire
    Longvert, Christine
    Blom, Astrid
    Saiag, Philippe
    Funck-Brentano, Elisa
    BRITISH JOURNAL OF CANCER, 2021, 125 (07) : 948 - 954
  • [28] A Review and Comparison of Immune-Checkpoint Inhibitors in the Treatment of Metastatic Uveal Melanoma
    Alam, Benyamin
    Akbari, Amir Reza
    Ageed, Ahmed
    Duffy, Ryan
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [29] Real-world effectiveness of immune checkpoint inhibitors and BRAF/ MEK inhibitors among veteran patients with cutaneous melanoma
    Kim, Daniel Y.
    Swetter, Susan M.
    Huhmann, Linden
    Dizon, Matthew P.
    Ferguson, Jacqueline M.
    Osborne, Thomas F.
    Spence, Allyson C.
    Ziad, Amina
    Fillmore, Nathanael
    Hartman, Rebecca I.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (03) : 620 - 623
  • [30] Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors
    Stadler, Julia-Christina
    Keller, Laura
    Mess, Christian
    Bauer, Alexander T.
    Koett, Julian
    Geidel, Glenn
    Heidrich, Isabel
    Vidal-Y-Sy, Sabine
    Andreas, Antje
    Stramaglia, Carlotta
    Sementsov, Mark
    Haberstroh, Wiebcke
    Deitert, Benjamin
    Hoehne, Inka Lilott
    Reschke, Robin
    Haalck, Thomas
    Pantel, Klaus
    Gebhardt, Christoffer
    Schneider, Stefan W.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (05)
12345